Last reviewed · How we verify
Shenyankangfu tablets
Shenyankangfu tablets is a traditional Chinese medicine formulation that supports kidney and cardiovascular function through multi-component herbal synergy.
Shenyankangfu tablets is a traditional Chinese medicine formulation that supports kidney and cardiovascular function through multi-component herbal synergy. Used for Hypertension, Cardiovascular support in kidney yang deficiency patterns.
At a glance
| Generic name | Shenyankangfu tablets |
|---|---|
| Sponsor | Chinese PLA General Hospital |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This is a proprietary Chinese herbal medicine combining multiple botanical ingredients traditionally used in Chinese medicine to tonify kidney yang, improve blood circulation, and support cardiovascular health. The formulation is designed to address deficiency patterns in traditional Chinese medicine theory that may contribute to hypertension and related cardiovascular conditions. The exact molecular mechanisms remain incompletely characterized in Western pharmacological terms.
Approved indications
- Hypertension
- Cardiovascular support in kidney yang deficiency patterns
Common side effects
Key clinical trials
- Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease (PHASE4)
- Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Shenyankangfu tablets CI brief — competitive landscape report
- Shenyankangfu tablets updates RSS · CI watch RSS
- Chinese PLA General Hospital portfolio CI